Skip to main content
Fig. 4 | European Journal of Medical Research

Fig. 4

From: Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice

Fig. 4

Treatment with BIBF1000 reduced allergen-induced airway and pulmonary arterial remodeling in mice. A Hematoxylin and eosin (HE) staining. B Airway wall thickness. C Pulmonary arterial wall thickness in each treatment group. All values are mean ± SEM, n = 8. #p < 0.05 vs. control, *p < 0.05 vs. vehicle

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us